FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2329352578> ?p ?o ?g. }

• W2329352578 endingPage "482" @default.
• W2329352578 startingPage "472" @default.
• W2329352578 abstract "Because of the rarity of uterine clear cell carcinoma (UCCC), a National Cancer Data Base analysis was conducted to evaluate practice patterns and implications of adjuvant therapy.The National Cancer Data Base was queried for UCCC patients diagnosed from 1998 to 2011. Patients receiving neoadjuvant therapy, lacking surgical staging, or having follow-up time shorter than 6 months were excluded. Factors associated with utilization were assessed using logistic regression. To define the probability of receiving chemotherapy and radiotherapy (CT + RT), propensity scores with inverse probability of treatment weighting (IPTW) were calculated using multivariable logistic regression. Log-rank test and multivariable IPTW-adjusted Cox proportional hazards modeling were then conducted.A total of 2504 patients were identified, with a median follow-up of 65.5 months. Most patients had FIGO (International Federation of Gynecology and Obstetrics) stage I to II UCCC (71.4%). Adjuvant RT alone, CT alone, or CT + RT was given in 35.3%, 9.5%, and 11.7%, respectively. Among those receiving RT, external beam was the most common modality (69.4%). Later year of diagnosis (>2005: odds ratio [OR], 4.42; 95% confidence interval [95% CI], 2.44-8.01), higher FIGO stage (IIIA-IIIC2: OR, 6.34; 95% CI, 3.93-10.24), larger tumor size (3.6-5.0 cm: OR, 3.40; 95% CI, 1.76-6.55), and lymph node dissection (OR, 4.22; 95% CI, 1.60-11.15) were associated with a higher chance of receiving CT + RT. With IPTW-adjusted multivariable analysis, CT + RT significantly decreased mortality risk in stage III to IVA patients (hazards ratio, 0.41; 95% CI, 0.22-0.77), trending toward benefit in stage I to II patients (hazards ratio, 0.53; 95% CI, 0.27-1.07).In this hospital-based registry analysis of UCCC, adjuvant CT + RT significantly reduced the risk of death, reaching statistical significance for stage III to IVA patients." @default.
• W2329352578 created "2016-06-24" @default.
• W2329352578 creator A5023468026 @default.
• W2329352578 creator A5028695126 @default.
• W2329352578 creator A5042787177 @default.
• W2329352578 creator A5073162662 @default.
• W2329352578 creator A5074401921 @default.
• W2329352578 creator A5078798271 @default.
• W2329352578 date "2016-03-01" @default.
• W2329352578 modified "2023-09-30" @default.
• W2329352578 title "Utilization and Role of Adjuvant Radiotherapy and Chemotherapy for Uterine Clear Cell Carcinoma" @default.
• W2329352578 cites W1968244916 @default.
• W2329352578 cites W1969737874 @default.
• W2329352578 cites W1974023896 @default.
• W2329352578 cites W1983158399 @default.
• W2329352578 cites W1994720359 @default.
• W2329352578 cites W2003038632 @default.
• W2329352578 cites W2019777872 @default.
• W2329352578 cites W2023519144 @default.
• W2329352578 cites W2032145935 @default.
• W2329352578 cites W2037374413 @default.
• W2329352578 cites W2037845737 @default.
• W2329352578 cites W2041044630 @default.
• W2329352578 cites W2051972737 @default.
• W2329352578 cites W2061365028 @default.
• W2329352578 cites W2067259348 @default.
• W2329352578 cites W2068953434 @default.
• W2329352578 cites W2072944634 @default.
• W2329352578 cites W2075816569 @default.
• W2329352578 cites W2079005973 @default.
• W2329352578 cites W2090192857 @default.
• W2329352578 cites W2097409147 @default.
• W2329352578 cites W2098960933 @default.
• W2329352578 cites W2105449075 @default.
• W2329352578 cites W2108556797 @default.
• W2329352578 cites W2115516019 @default.
• W2329352578 cites W2122242737 @default.
• W2329352578 cites W2142495742 @default.
• W2329352578 cites W2147101451 @default.
• W2329352578 cites W2151254090 @default.
• W2329352578 cites W2152590022 @default.
• W2329352578 cites W2163650867 @default.
• W2329352578 cites W2170877346 @default.
• W2329352578 cites W3025735868 @default.
• W2329352578 cites W4248897936 @default.
• W2329352578 cites W76374557 @default.
• W2329352578 doi "https://doi.org/10.1097/igc.0000000000000640" @default.
• W2329352578 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26825837" @default.
• W2329352578 hasPublicationYear "2016" @default.
• W2329352578 type Work @default.
• W2329352578 sameAs 2329352578 @default.
• W2329352578 citedByCount "7" @default.
• W2329352578 countsByYear W23293525782016 @default.
• W2329352578 countsByYear W23293525782017 @default.
• W2329352578 countsByYear W23293525782018 @default.
• W2329352578 countsByYear W23293525782019 @default.
• W2329352578 countsByYear W23293525782020 @default.
• W2329352578 countsByYear W23293525782022 @default.
• W2329352578 crossrefType "journal-article" @default.
• W2329352578 hasAuthorship W2329352578A5023468026 @default.
• W2329352578 hasAuthorship W2329352578A5028695126 @default.
• W2329352578 hasAuthorship W2329352578A5042787177 @default.
• W2329352578 hasAuthorship W2329352578A5073162662 @default.
• W2329352578 hasAuthorship W2329352578A5074401921 @default.
• W2329352578 hasAuthorship W2329352578A5078798271 @default.
• W2329352578 hasConcept C126322002 @default.
• W2329352578 hasConcept C126838900 @default.
• W2329352578 hasConcept C143998085 @default.
• W2329352578 hasConcept C146357865 @default.
• W2329352578 hasConcept C151730666 @default.
• W2329352578 hasConcept C151956035 @default.
• W2329352578 hasConcept C156957248 @default.
• W2329352578 hasConcept C2780849966 @default.
• W2329352578 hasConcept C44249647 @default.
• W2329352578 hasConcept C50382708 @default.
• W2329352578 hasConcept C509974204 @default.
• W2329352578 hasConcept C71924100 @default.
• W2329352578 hasConcept C86803240 @default.
• W2329352578 hasConceptScore W2329352578C126322002 @default.
• W2329352578 hasConceptScore W2329352578C126838900 @default.
• W2329352578 hasConceptScore W2329352578C143998085 @default.
• W2329352578 hasConceptScore W2329352578C146357865 @default.
• W2329352578 hasConceptScore W2329352578C151730666 @default.
• W2329352578 hasConceptScore W2329352578C151956035 @default.
• W2329352578 hasConceptScore W2329352578C156957248 @default.
• W2329352578 hasConceptScore W2329352578C2780849966 @default.
• W2329352578 hasConceptScore W2329352578C44249647 @default.
• W2329352578 hasConceptScore W2329352578C50382708 @default.
• W2329352578 hasConceptScore W2329352578C509974204 @default.
• W2329352578 hasConceptScore W2329352578C71924100 @default.
• W2329352578 hasConceptScore W2329352578C86803240 @default.
• W2329352578 hasIssue "3" @default.
• W2329352578 hasLocation W23293525781 @default.
• W2329352578 hasLocation W23293525782 @default.
• W2329352578 hasOpenAccess W2329352578 @default.
• W2329352578 hasPrimaryLocation W23293525781 @default.
• W2329352578 hasRelatedWork W2037611947 @default.
• W2329352578 hasRelatedWork W2069785877 @default.

• next